Name: 글로벌 시장 동향
SKU: CD2683
Availability: InStock

보고서 요약(국문)

시장 개요
글로벌 의료 분석 테스트 서비스 시장은 2022년 64억 달러 규모에 도달했으며, 2030년까지 147억 달러 규모로 성장할 것으로 예상됩니다. 글로벌 의료 분석 테스트 서비스 시장은 예측 기간(2023~2030년) 동안 연평균 11.1%의 성장률을 보일 것으로 전망됩니다.
의료 분석 테스트 서비스는 잠재적 위험을 식별하고 의료 기기, 의약품 및 기타 의료 제품의 품질과 효능을 보장하는 테스트를 수행하여 환자의 안전을 보호하는 데 도움을 줍니다. 이러한 테스트는 오염 물질을 식별하고, 제품의 무결성을 검증하며, 환자에게 위협이 될 수 있는 유해 물질을 감지하는 데 도움이 됩니다.
테스트 서비스는 다양한 치료법의 효과를 평가하는 데 기여합니다. 임상 시험 및 연구는 치료 결과를 측정하고, 체내 약물 농도를 평가하고, 질병 진행 또는 치료 반응의 생체 지표를 평가하기 위해 분석 테스트에 의존합니다.

시장 동향
실험실 검사 서비스 아웃소싱 증가 추세가 시장 성장을 견인할 것입니다.
실험실 검사 서비스 아웃소싱 추세가 증가함에 따라 기업들은 다양한 서비스와 솔루션을 제공하며 시장 점유율을 확대하고 있습니다. 주요 업체들은 인수합병 및 기타 전략에도 집중하고 있습니다.
예를 들어, 유로핀스 사이언티픽(Eurofins Scientific)은 2021년 8월 일본 내 검사 서비스 범위를 확대하기 위해 노리츠 코키(Noritsu Koki Co. Ltd.)와 일본 유전자 분석 분야 주요 업체인 제네텍(GeneTech Inc.) 인수 계약을 체결했습니다. 생물 분석 검사 서비스의 중요성이 커짐에 따라 시장은 빠르게 성장할 것으로 예상됩니다. 따라서 주요 업체들의 확장 전략은 시장 성장에 기여하고 있습니다.
감염성 질환 증가가 시장 성장을 견인할 것입니다.
뎅기열, HIV 등 감염성 질환의 증가 추세가 시장 성장을 견인할 것입니다. 예를 들어, 세계보건기구(WHO)에 따르면 사람을 무는 모기에 감염되는 뎅기 바이러스(DENV)는 뎅기열로 알려진 바이러스 감염을 유발합니다. 현재 전 세계 인구의 약 절반이 뎅기열 위험에 노출되어 있으며, 매년 1억~5억 건의 감염이 발생하는 것으로 추정됩니다. 뎅기열은 열대 및 아열대 지역에서 발생하는 질병으로 주로 도시 및 준도시 지역에 영향을 미칩니다. 감염병이 증가함에 따라 실험실 분석이 필수적이며, 의료 분석 검사 서비스 시장은 향후 몇 년 동안 성장할 것으로 예상됩니다.
데이터 보안 취약성이 시장 성장을 저해할 것입니다.
의료 분석 검사 서비스에서 데이터 보안 문제를 해결하려면 강력한 사이버 보안 조치, 정기적인 보안 평가, 직원 교육 및 관련 규정 준수를 포함하는 다각적인 접근 방식이 필요합니다. 의료 기관은 환자 데이터 보호에 투자하고 진화하는 사이버 위협에 대해 경계를 늦추지 않는 것이 중요합니다. 따라서 위의 요인들이 시장 성장을 제한할 것입니다.
코로나19 영향 분석
코로나19 팬데믹은 의료 분석 검사 서비스에 상당한 영향을 미쳤습니다. 검사 수요 증가, 새로운 검사 방법 및 기술 도입 가속화, 실험실 자원 부담 증가, 우선순위 재편 등이 그 예입니다. 여러 어려움에도 불구하고, 팬데믹은 혁신과 협력을 촉진하여 검사 방법론의 발전과 자동화 및 AI를 의료 분석 검사 서비스에 통합하는 데 기여했습니다.
러시아-우크라이나 전쟁 영향 분석
러시아-우크라이나 분쟁은 해당 지역의 주요 시장 참여자 수가 적기 때문에 전 세계 의료 분석 검사 서비스 시장에 중간 정도의 영향을 미칠 것으로 예상됩니다. 그러나 원자재 수출입의 영향은 예측 기간 동안 전 세계 의료 분석 검사 서비스 시장 성장에 미미한 영향을 미칠 것으로 예상됩니다.
인공지능(AI) 영향 분석
AI 기반 알고리즘은 X선, CT 스캔, MRI와 같은 의료 영상을 매우 정확하게 분석할 수 있습니다. 딥러닝 알고리즘은 인간 전문가가 식별하기 어려운 이상, 병변 및 패턴을 감지할 수 있습니다. 이는 방사선 전문의가 정확한 진단을 내리고 오류를 줄이며 환자 결과를 개선하는 데 도움이 됩니다. AI는 데이터 분석 및 해석부터 예측 분석, 영상 분석, 유전체 분석, 신약 개발, 품질 관리 및 워크플로 최적화에 이르기까지 의료 분석 검사 서비스 분야에서 상당한 이점을 제공합니다.

시장 세분화 분석
글로벌 의료 분석 테스트 서비스 시장은 테스트 유형, 최종 사용자 및 지역별로 세분화됩니다.
최종 사용자 부문에서 제약 및 바이오 제약 회사가 시장 점유율의 38.3%를 차지합니다.
주요 기업들의 전략이 이 부문의 성장을 주도할 것입니다. 예를 들어, Thermo Fisher는 2022년 10월 24일 9,700만 달러 규모의 확장 계획의 일환으로 임상 연구 시설을 추가했습니다.
이 회사는 미국에 생물 분석 연구소를 설립하여 전체 시설에 59,000평방피트의 공간을 추가하여 "동종 최대 규모의 연구소 중 하나"로 만들었습니다. 이 새로운 생물 분석 시설은 Thermo Fisher가 버지니아주 리치먼드에 투자할 총 9,700만 달러(9,900만 유로) 투자 계획의 일부입니다. 회사 측은 이 연구소가 신약 개발 과정에서 실험실 서비스를 제공하는 데 사용될 것이라고 밝혔습니다. 결과적으로 시장 성장은 주요 기업들의 기업 확장 및 협력에 의해 주도될 것입니다.

지리적 분석
아시아 태평양 지역은 시장 점유율의 약 25.4%를 차지했습니다.
이는 선진국 기업들의 지역 분석 서비스 개선 투자 증가, 규제 기관의 평가 기준 국제 표준 준수를 위한 변경, 그리고 지역 내 다양한 지역으로 서비스 범위를 확장하기 위한 새로운 시설 구축 및 제휴 덕분입니다.
예를 들어, 2021년 5월 19일, 세계적인 생명과학 기업인 Labcorp는 아시아 태평양 지역의 신약 개발 서비스에 싱가포르에서의 생물 분석 서비스 제공을 추가한다고 발표했습니다. 싱가포르는 Labcorp의 광범위한 글로벌 입지를 강화하는 데 중요한 지역으로, 고객에게 국내외 생물 분석 연구를 지원하는 보완적인 거점을 제공합니다.
또한, 2021년 8월 4일에는 Agilex Biolabs가 아시아 태평양 지역 확장 계획의 일환으로 TetraQ를 인수했습니다. Agilex Biolabs는 생물학적 제제 및 소분자 화합물의 약물동태학(PK), 면역원성, 바이오마커 및 면역학적 약동학 평가를 위한 생체분석 전문 기업입니다. TetraQ는 숙련된 인력과 수십 년간 축적된 규제 생체분석 서비스 경험을 바탕으로 호주 및 아시아 태평양 지역에서 Agilex Biolabs의 사업을 보완합니다. 따라서 앞서 언급한 요소들이 시장 성장을 주도하고 있습니다.

경쟁 환경
헬스케어 분석 시험 서비스 시장의 주요 글로벌 기업으로는 Pharmaceutical Product Development, LLC(PPD), Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc., Steris, Charles River Laboratories 등이 있습니다.

보고서 구매 이유

• 시험 유형, 최종 사용자 및 지역별 글로벌 헬스케어 분석 시험 서비스 시장 세분화 현황을 시각화하고 주요 기업 및 사업자를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 모색합니다.

• 모든 세그먼트를 포함한 의료 분석 테스트 서비스 시장 수준의 다양한 데이터 포인트가 담긴 엑셀 데이터 시트.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 엑셀 파일 제공.
글로벌 의료 분석 테스트 서비스 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Healthcare Analytical Testing Services Market reached US$ 6.4 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 14.7 billion by 2030. The global Healthcare Analytical Testing Services Market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030).
Healthcare analytical testing services help safeguard patient safety by conducting tests to identify potential risks and ensure the quality and efficacy of medical devices, pharmaceuticals, and other healthcare products. These tests help identify contaminants, verify product integrity, and detect any harmful substances that could pose a threat to patients.
Testing services contribute to evaluating the effectiveness of different treatment modalities. Clinical trials and studies rely on analytical testing to measure treatment outcomes, assess drug concentrations in the body, and evaluate biomarkers of disease progression or treatment response.
Market Dynamics
Rising Trend of Outsourcing Laboratory Testing Services Will Drive The Market Growth
Companies are growing their market share by providing a variety of services and solutions as a result of the rising trend of outsourcing laboratory testing services. Major players are also concentrating on other strategies, including mergers, acquisitions, and other advances.
For instance, in August 2021, to increase the scope of its testing offerings in Japan, Eurofins Scientific entered into a contract with Noritsu Koki Co. Ltd to purchase GeneTech Inc., a major participant in genetic analysis in Japan.The market is expected to increase rapidly since the bioanalytical testing service is crucial. Therefore, prominent players' expanding strategies contribute to the growth of the market.
Increasing Prevalence Of Infectious Diseases Will Drive The Market Growth
The increasing prevalence of infectious diseases like dengue, HIV and others will drive the market growth. For instance, according to WHO, the dengue virus (DENV), which infects mosquitoes that bite people, causes the viral infection known as dengue. Approximately half of the world's population is now at risk for dengue, with 100-500 million infections thought to occur annually. Dengue is a tropical and subtropical disease that primarily affects urban and semi-urban settings. Although it must be analyzed in laboratories since infectious diseases are on the rise, the market for healthcare analytical testing services will expand in the next years.
Data Insecurity Will Hamper The Market Growth.
Addressing data insecurity in healthcare analytical testing services requires a multi-faceted approach involving robust cybersecurity measures, regular security assessments, employee training, and compliance with relevant regulations. It is crucial for healthcare organizations to invest in the protection of patient data and stay vigilant in the face of evolving cyber threats. Thus above factors restrict the market growth.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on healthcare analytical testing services. It led to increased testing demand, accelerated the adoption of new testing methods and technologies, strained laboratory resources, and reshaped priorities. Despite the challenges, the pandemic also spurred innovation and collaboration, driving advancements in testing methodologies and the integration of automation and AI into healthcare analytical testing services.
Russia-Ukraine War Impact Analysis
The Russia-Ukraine conflict is estimated to have a moderate impact on the global Healthcare Analytical Testing Services market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global Healthcare Analytical Testing Servicesmarket growth over the forecast period.
Artificial Intelligence Impact Analysis
AI-powered algorithms can analyze medical images, such as X-rays, CT scans, and MRIs, with remarkable precision. Deep learning algorithms can detect anomalies, lesions, and patterns that might be difficult for human experts to identify. This assists radiologists in making accurate diagnoses, reducing errors, and improving patient outcomes. AI offers significant advantages in healthcare analytical testing services, ranging from data analysis and interpretation to predictive analytics, image analysis, genomic analysis, drug discovery, quality control, and workflow optimization.
Segment Analysis
The global healthcare analytical testing servicesmarket is segmented based on test type, end user and region.
Pharmaceutical & Biopharmaceutical Companies from End user Segment Accounts for 38.3% of Market Share.
The strategies of the key players will dominate the segment’s growth. For instance, on October 24, 2022, as part of its $97 million expansion, Thermo Fisher added a clinical research facility.
The business establishes a bioanalytical lab in the US, adding 59,000 square feet of additional space to the facility overall, making it "one of the largest laboratories of its kind." The new bioanalytical facility is part of a $97 million (€99 million) total investment that Thermo Fisher will make at the Richmond, Virginia, location. The lab will be utilized to offer laboratory services in the drug development process, the company claims. As a result, market growth will be dominated by key players' company expansion and collaboration.
Geographical Analysis
Asia Pacific Accounted for Approximately 25.4% of the Market Share
Due to increased investments made in improving regional analytical services by businesses from developed economies, changes made to evaluation standards by regulatory bodies to bring them into line with international standards, and the creation of new facilities and alliances to expand the reach of their offerings to different regions in the region.
For instance, on May 19, 2021, Leading global life sciences company announced the addition of bioanalytical services in Singapore to its drug development offering in the Asia-Pacific region. And Singapore is a significant region for bolstering Labcorp's vast global presence because it provides clients of the company with a complementary site to support their bioanalytical research, both domestically and internationally.
Additionally, August 04, 2021, TetraQ has been acquired by Agilex Biolabs as part of its APAC expansion plans. Agilex Biolabs specialises in the bioanalysis of biologics and small compounds for PK, immunogenicity, biomarker, and immunological pharmacodynamics assessments. With its knowledgeable workforce and decades of experience in regulated bioanalytical services, TetraQ complements the work of Agilex Biolabs in Australia and the APAC region. Thus, the aforementioned variables predominate market growth.
Competitive Landscape
The major global players in the healthcare analytical testing services market include Pharmaceutical Product Development, LLC (PPD), Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc., Steris, Charles River Laboratories and among others.
Why Purchase the Report?
• To visualize the global healthcare analytical testing services market segmentation based on test type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of Healthcare Analytical Testing Services market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global Healthcare Analytical Testing Services market report would provide approximately 53 tables, 54 figures and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Test Type
3.2. Snippet by End User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising clinical trials will drive the market growth
4.1.1.2. Increasing growth for bioanalytical testing services
4.1.2. Restraints
4.1.2.1. Data Insecurity will hamper the market growth
4.1.3. Opportunity
4.1.3.1. The increasing focus on preventive healthcare and early disease detection
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. Artificial Intelligence Impact
8. ByTest Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
8.1.2. Market Attractiveness Index, By Test Type
8.2. Bioanalytical Testing Services*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Method Development & Validation
8.4. Stability Testing
8.5. Drug Substances
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Pharmaceutical & Biopharmaceutical Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Device Companies
9.4. Contract Research Organizations
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.5.1. The U.S.
10.2.5.2. Canada
10.2.5.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.5.1. Germany
10.3.5.2. The U.K.
10.3.5.3. France
10.3.5.4. Spain
10.3.5.5. Italy
10.3.5.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.5.1. Brazil
10.4.5.2. Argentina
10.4.5.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.5.1. China
10.5.5.2. India
10.5.5.3. Japan
Australia
10.5.5.4. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Pharmaceutical Product Development, LLC (PPD)*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Eurofins Scientific
12.3. SGS SA
12.4. Toxikon Inc.
12.5. Pace Analytical Services
12.6. Intertek Pharmaceutical Services
12.7. Boston Analytical
12.8. West Pharmaceutical Services Inc.
12.9. Steris
12.10. Charles River Laboratories.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Pharmaceutical Product Development, LLC (PPD), 4.	Key Developments, Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc., Steris, Charles River Laboratories.

표 목록 (Tables)

List of Tables

Table 1 Global Healthcare Analytical Testing Services Market Value, By Test Type, 2022, 2026 & 2030 (US$ Billion)

Table 2 Global Healthcare Analytical Testing Services Market Value, By End User, 2022, 2026 & 2030 (US$ Billion)

Table 3 Global Healthcare Analytical Testing Services Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 4 Global Healthcare Analytical Testing Services Market Value, By Test Type, 2022, 2026 & 2030 (US$ Billion)

Table 5 Global Healthcare Analytical Testing Services Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 6 Global Healthcare Analytical Testing Services Market Value, By End User, 2022, 2026 & 2030 (US$ Billion)

Table 7 Global Healthcare Analytical Testing Services Market Value, By End User, 2021-2030 (US$ Billion)

Table 8 Global Healthcare Analytical Testing Services Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 9 Global Healthcare Analytical Testing Services Market Value, By Region, 2021-2030 (US$ Billion)

Table 10 North America Healthcare Analytical Testing Services Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 11 North America Healthcare Analytical Testing Services Market Value, By End User, 2021-2030 (US$ Billion)

Table 12 North America Healthcare Analytical Testing Services Market Value, By Country, 2021-2030 (US$ Billion)

Table 13 South America Healthcare Analytical Testing Services Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 14 South America Healthcare Analytical Testing Services Market Value, By End User, 2021-2030 (US$ Billion)

Table 15 South America Healthcare Analytical Testing Services Market Value, By Country, 2021-2030 (US$ Billion)

Table 16 Europe Healthcare Analytical Testing Services Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 17 Europe Healthcare Analytical Testing Services Market Value, By End User, 2021-2030 (US$ Billion)

Table 18 Europe Healthcare Analytical Testing Services Market Value, By Country, 2021-2030 (US$ Billion)

Table 19 Asia-Pacific Healthcare Analytical Testing Services Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 20 Asia-Pacific Healthcare Analytical Testing Services Market Value, By End User, 2021-2030 (US$ Billion)

Table 21 Asia-Pacific Healthcare Analytical Testing Services Market Value, By Country, 2021-2030 (US$ Billion)

Table 22 Middle East & Africa Healthcare Analytical Testing Services Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 23 Middle East & Africa Healthcare Analytical Testing Services Market Value, By End User, 2021-2030 (US$ Billion)

Table 24 Pharmaceutical Product Development, LLC (PPD): Overview

Table 25 Pharmaceutical Product Development, LLC (PPD): Product Portfolio

Table 26 Pharmaceutical Product Development, LLC (PPD): Key Developments

Table 27 Eurofins Scientific: Overview

Table 28 Eurofins Scientific: Product Portfolio

Table 29 Eurofins Scientific: Key Developments

Table 30 SGS SA: Overview

Table 31 SGS SA: Product Portfolio

Table 32 SGS SA: Key Developments

Table 33 Toxikon Inc.: Overview

Table 34 Toxikon Inc.: Product Portfolio

Table 35 Toxikon Inc.: Key Developments

Table 36 Pace Analytical Services: Overview

Table 37 Pace Analytical Services: Product Portfolio

Table 38 Pace Analytical Services: Key Developments

Table 39 Intertek Pharmaceutical Services: Overview

Table 40 Intertek Pharmaceutical Services: Product Portfolio

Table 41 Intertek Pharmaceutical Services: Key Developments

Table 42 Boston Analytical: Overview

Table 43 Boston Analytical: Product Portfolio

Table 44 Boston Analytical: Key Developments

Table 45 West Pharmaceutical Services Inc.: Overview

Table 46 West Pharmaceutical Services Inc.: Product Portfolio

Table 47 West Pharmaceutical Services Inc.: Key Developments

Table 48 Steris: Overview

Table 49 Steris: Product Portfolio

Table 50 Steris: Key Developments

Table 51 Charles River Laboratories: Overview

Table 52 Charles River Laboratories: Product Portfolio

Table 53 Charles River Laboratories: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 2 Global Healthcare Analytical Testing Services Market Share, By Test Type, 2022 & 2030 (%)

Figure 3 Global Healthcare Analytical Testing Services Market Share, By End User, 2022 & 2030 (%)

Figure 4 Global Healthcare Analytical Testing Services Market Share, By Region, 2022 & 2030 (%)

Figure 5 Global Healthcare Analytical Testing Services Market Y-o-Y Growth, By Test Type, 2022-2030 (%)

Figure 6 Bioanalytical Testing Services Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 7 Method Development & Validation Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 8 Stability Testing Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 9 Drug Substances Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 10 Others Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 11 Global Healthcare Analytical Testing Services Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 12 Pharmaceutical & Biopharmaceutical Companies End User in Global Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 13 Medical Device Companies End User in Global Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 14 Contract Research Organizations End User in Global Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 15 Others End User in Global Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 16 Global Healthcare Analytical Testing Services Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 17 North America Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 18 Asia-Pacific Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 19 Europe Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 20 South America Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 21 Middle East and Africa Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 22 North America Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 23 North America Healthcare Analytical Testing Services Market Share, By Test Type, 2022 & 2030 (%)

Figure 24 North America Healthcare Analytical Testing Services Market Share, By End User, 2022 & 2030 (%)

Figure 25 North America Healthcare Analytical Testing Services Market Share, By Country, 2022 & 2030 (%)

Figure 26 South America Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 27 South America Healthcare Analytical Testing Services Market Share, By Test Type, 2022 & 2030 (%)

Figure 28 South America Healthcare Analytical Testing Services Market Share, By End User, 2022 & 2030 (%)

Figure 29 South America Healthcare Analytical Testing Services Market Share, By Country, 2022 & 2030 (%)

Figure 30 Europe Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 31 Europe Healthcare Analytical Testing Services Market Share, By Test Type, 2022 & 2030 (%)

Figure 32 Europe Healthcare Analytical Testing Services Market Share, By End User, 2022 & 2030 (%)

Figure 33 Europe Healthcare Analytical Testing Services Market Share, By Country, 2022 & 2030 (%)

Figure 34 Asia-Pacific Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 35 Asia-Pacific Healthcare Analytical Testing Services Market Share, By Test Type, 2022 & 2030 (%)

Figure 36 Asia-Pacific Healthcare Analytical Testing Services Market Share, By End User, 2022 & 2030 (%)

Figure 37 Asia-Pacific Healthcare Analytical Testing Services Market Share, By Country, 2022 & 2030 (%)

Figure 38 Middle East & Africa Healthcare Analytical Testing Services Market Value, 2021-2030 (US$ Billion)

Figure 39 Middle East & Africa Healthcare Analytical Testing Services Market Share, By Test Type, 2022 & 2030 (%)

Figure 40 Middle East & Africa Healthcare Analytical Testing Services Market Share, By End User, 2022 & 2030 (%)

Figure 41 Pharmaceutical Product Development, LLC (PPD): Financials

Figure 42 Eurofins Scientific: Financials

Figure 43 SGS SA: Financials

Figure 44 Toxikon Inc.: Financials

Figure 45 Pace Analytical Services: Financials

Figure 46 Intertek Pharmaceutical Services: Financials

Figure 47 Boston Analytical: Financials

Figure 48 West Pharmaceutical Services Inc.: Financials

Figure 49 Steris: Financials

Figure 50 Charles River Laboratories: Financials

글로벌 의료 분석 테스트 서비스 시장 – 2023-2030

Global Healthcare Analytical Testing Services Market - 2023-2030